Analyst Consensus ?
ConsensusBuy29 ratings
Bullish1551.7%
Neutral1448.3%
Bearish00.0%
IDEX Corporation · IEX · FY2026 Q2 · Calendar Q3 2026
IDEX raises outlook as HST orders surge and capex increases
IDEX’s Q2 update strengthens the growth case: orders accelerated sharply, HST demand was the main engine, and management raised its full-year outlook. The counterweight is that tariff refunds aided Q2 results and the outlook relies on sustained advantaged-market demand plus successful capacity and acquisition execution.
Reported Before market openNYSEIndustrials
$16.64B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$2.32
Consensus $2.11
EPS surprise
+10.0%
Reported versus consensus
Reported revenue
$920.6M
Consensus $905.4M
Revenue surprise
+1.7%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+2.2%
Event window
SPY move
-1.5%
Same window
Abnormal move
+3.7%
Stock minus SPY
Volume
2.4×
Versus trailing sessions
Subsequent drift
+2.3%
Up to 20 sessions
IEXSPY benchmark
Ask FN2 about IEX FY2026 Q2
Transcript, numbers and history already loaded
Why did IEX rise 2.2% after beating EPS estimates in FY2026 Q2?What changed in IEX's guidance and outlook in FY2026 Q2?Give me the bull and bear case for IEX after FY2026 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current quarter showed stronger order momentum than the prior quarter, with HST leading the acceleration. Management raised full-year growth, margin, and EPS guidance, increased capex to support capacity, and highlighted backlog extending into 2027; tariff refunds also provided a disclosed Q2 benefit.
Guidance delta
Management raised full-year 2026 guidance to 5–6% organic growth, 27–27.3% EBITDA margin, and $8.70–$8.85 EPS; capex guidance increased to $110 million.
Key takeaways
- Q2 organic sales increased 5%, while adjusted EPS was $2.32.
- Organic orders rose 28%, led by 47% growth in HST.
- Management cited data-center, semiconductor, and space-and-defense demand as key drivers.
- Backlog and capacity plans support a higher investment outlook through 2027–2028.
- IEEPA tariff refunds benefited Q2 EPS and gross margin, complicating comparisons.
Management priorities
- Expand capacity and throughput for data-center and semiconductor demand.
- Grow recurring revenue in HST filtration and life-science optical solutions.
- Pursue selective bolt-on acquisitions under the 8020 framework.
- Continue focusing capital on higher-return businesses and margin expansion.
- Maintain quarterly share repurchases near $75 million, subject to leverage and M&A.
Follow IEX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$229.41Current
$205Low
$243.75Average
$280High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 23, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Oppenheimer | Outperform | Outperform | Maintain | Sep 9, 2026 |
| Mizuho | Outperform | Neutral | Upgrade | Aug 12, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 6, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 30, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 30, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Mar 27, 2026 |
| Baird | Outperform | Outperform | Maintain | Oct 31, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 28, 2023 |
| Bernstein | Market Perform | Market Perform | Maintain | Apr 28, 2023 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 18, 2023 |
| Loop Capital | Hold | Hold | Maintain | Jul 19, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Mar 9, 2022 |
| Rosenblatt | Buy | Buy | Maintain | May 3, 2021 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Apr 8, 2020 |
| Janney Capital | Neutral | Buy | Downgrade | Apr 8, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 29, 2019 |
| Berenberg | Buy | Buy | Maintain | May 15, 2019 |
| UBS | Neutral | Neutral | Maintain | Jan 23, 2018 |
| KeyBanc | Equal Weight | Sector Weight | Maintain | May 23, 2016 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Nov 3, 2015 |
| Jefferies | Hold | Hold | Maintain | Jun 12, 2015 |
| Brean Capital | Buy | Hold | Upgrade | Jan 30, 2014 |
| Longbow Research | Neutral | Neutral | Maintain | Oct 1, 2013 |
| BB&T Capital | Hold | Hold | Maintain | Mar 15, 2013 |
| CL King | Neutral | Buy | Downgrade | Dec 12, 2012 |
| Barrington Research | Outperform | Outperform | Maintain | Jul 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $229.41. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Oppenheimer | Analyst unavailable | $270 | $225.66 | +17.7% | Sep 9, 2026 |
| Vertical Research | Jeffrey Sprague | $250 | $223.74 | +9.0% | Sep 8, 2026 |
| Mizuho Securities | Brett Linzey | $280 | $237.31 | +22.1% | Aug 11, 2026 |
| D.A. Davidson | Analyst unavailable | $240 | $234.88 | +4.6% | Aug 6, 2026 |
| Oppenheimer | Analyst unavailable | $265 | $236.82 | +15.5% | Jul 30, 2026 |
| Stifel Nicolaus | Nathan Jones | $268 | $229.52 | +16.8% | Jul 30, 2026 |
| Stifel Nicolaus | Nathan Jones | $257 | $224.94 | +12.0% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $261 | $227.6 | +13.8% | Jul 16, 2026 |
| Oppenheimer | Analyst unavailable | $250 | $207.59 | +9.0% | Jun 2, 2026 |
| Seaport Global | Walt Liptak | $250 | $215.78 | +9.0% | May 5, 2026 |
| RBC Capital | Analyst unavailable | $252 | $217.93 | +9.8% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $250 | $217.68 | +9.0% | Apr 30, 2026 |
| Oppenheimer | Analyst unavailable | $242 | $217.34 | +5.5% | Apr 30, 2026 |
| Robert W. Baird | Analyst unavailable | $257 | $217.34 | +12.0% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $241 | $205.12 | +5.1% | Apr 14, 2026 |
| BMO Capital | Analyst unavailable | $214 | $189.73 | -6.7% | Mar 26, 2026 |
| Seaport Global | Analyst unavailable | $240 | $212.26 | +4.6% | Feb 9, 2026 |
| Argus Research | Analyst unavailable | $240 | $212.94 | +4.6% | Feb 6, 2026 |
| RBC Capital | Analyst unavailable | $244 | $211.02 | +6.4% | Feb 5, 2026 |
| Oppenheimer | Bryan Blair | $230 | $209.86 | +0.3% | Feb 5, 2026 |
| Robert W. Baird | Michael Halloran | $247 | $212.25 | +7.7% | Feb 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $220 | $196.43 | -4.1% | Jan 23, 2026 |
| RBC Capital | Analyst unavailable | $211 | $194.99 | -8.0% | Jan 15, 2026 |
| RBC Capital | Analyst unavailable | $195 | $175.97 | -15.0% | Oct 30, 2025 |
| Stifel Nicolaus | Analyst unavailable | $191 | $167.51 | -16.7% | Oct 20, 2025 |
| Oppenheimer | Analyst unavailable | $210 | $167.05 | -8.5% | Oct 7, 2025 |
| D.A. Davidson | Analyst unavailable | $180 | $158.25 | -21.5% | Aug 4, 2025 |
| Mizuho Securities | Brett Linzey | $185 | $190.85 | -19.4% | May 16, 2025 |
| Robert W. Baird | Michael Halloran | $215 | $181.45 | -6.3% | May 2, 2025 |
| Mizuho Securities | Brett Linzey | $175 | $166.4 | -23.7% | Apr 22, 2025 |
| RBC Capital | Deane Dray | $248 | $218.64 | +8.1% | Oct 31, 2024 |
| D.A. Davidson | Matt Summerville | $210 | $194.12 | -8.5% | Aug 5, 2024 |
| Oppenheimer | Bryan Blair | $238 | $192.75 | +3.7% | Aug 5, 2024 |
| Robert W. Baird | Michael Halloran | $256 | $224.64 | +11.6% | Apr 25, 2024 |
| Stifel Nicolaus | Nathan Jones | $265 | $225.83 | +15.5% | Feb 8, 2024 |
| Stifel Nicolaus | Nathan Jones | $188 | $186.26 | -18.1% | Jul 18, 2022 |
| RBC Capital | Deane Dray | $238 | $188.06 | +3.7% | May 9, 2022 |
| Citigroup | Analyst unavailable | $235 | $191.15 | +2.4% | Apr 28, 2022 |
| Mizuho Securities | Analyst unavailable | $205 | $191.42 | -10.6% | Apr 28, 2022 |
| Bernstein | Brendan Luecke | $230 | $224.3 | +0.3% | Jan 10, 2022 |
| D.A. Davidson | Matt Summerville | $220 | $222.43 | -4.1% | Oct 28, 2021 |
| Morgan Stanley | Connor Lynagh | $250 | $225.91 | +9.0% | Apr 29, 2021 |
Track every rating change on IEX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationIDEX Corporation is an international enterprise specializing in engineered solutions across diverse sectors. The company operates through three primary business units: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT division is responsible for the design, production, and distribution of a range of fluid-handling equipment, including positive displacement pumps, flow meters, and injectors, alongside offering flow monitoring and related services. Its applications span the food, chemical, general industrial, water management, agricultural, and energy industries. Under the HST umbrella, IDEX develops and supplies precision components and systems for health and scientific applications.…
Historical context
All IEX earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
| DCI Donaldson Company, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1.8% | +2.1% | Donaldson posts record FY26 and targets further growth |
Latest beats and misses
Who reports nextBeat on EPS
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
Get the IEX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-07-29T21:05:46.442761+00:00
- FN2 earnings calendar · 2026-09-03T01:23:14.877038+00:00
- Polygon adjusted daily market bars · 2026-09-23T17:40:58.926991+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-23T17:40:58.924051+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.